Non-Human Primate (NHP) Bioanalysis & Biomarker Evaluation Services

Are you currently facing challenges in streamlining your drug development cycles, obtaining deep insights into target engagement, or navigating complex regulatory requirements for novel biologics? Our NHP Bioanalysis & Biomarker services help you accelerate your research and de-risk your programs through comprehensive, high-throughput analytical platforms and expert-guided data interpretation.

Overview of NHP Bioanalysis & Biomarker

Non-human primates (NHPs) remain a cornerstone of biomedical research due to their unparalleled genetic and physiological similarities to humans, serving as a critical bridge between preclinical models and clinical trials. This is particularly vital for biologics, gene therapies, and vaccines, where their complex immune and central nervous systems are the only suitable models.

What Our Service Is

Our service provides a full suite of analytical solutions to comprehensively profile biological samples from NHPs, from both invasive and non-invasive matrices. We specialize in generating actionable data to support your project at every stage.

• PK/TK Sample Analysis: We analyze pharmacokinetic (PK) and toxicokinetic (TK) properties of drug candidates, providing essential data on drug exposure, metabolism, and safety.
  Application Scenario: Determining the dose-response relationship of a novel monoclonal antibody in a primate model to inform first-in-human dose selection.
• ADA/Immunogenicity Testing: We assess the potential for a therapeutic to elicit an anti-drug antibody (ADA) response, a critical safety and efficacy concern.
  Application Scenario: Screening for immunogenic reactions to a new gene therapy vector to predict and mitigate potential adverse effects in clinical trials.
• Biomarker Profiling: We measure a wide range of biomarkers—including cytokines, hormones, and metabolites—to monitor disease progression, evaluate therapeutic response, and confirm target engagement.
  Application Scenario: Tracking changes in key inflammatory cytokines in response to an anti-inflammatory drug to demonstrate its mechanism of action.
• Multi-Omics & Data Reporting: Our multi-omics approach integrates data from multiple biological layers (e.g., proteomics, transcriptomics) to provide a holistic view of the biological system. We identify complex biomarkers, such as those related to aging or disease, providing deep insights into molecular mechanisms.
  Application Scenario: Using multi-omics analysis to identify novel aging-related biomarkers in rhesus monkeys to support a new anti-aging therapeutic.

Why Choose Us?

We understand the pressures facing modern NHP research—ethical scrutiny, high costs, and supply chain constraints. We provide a solution that turns these challenges into an advantage, creating unparalleled value for our clients.

• Pain Point: The need to generate maximum data from precious, limited NHP samples.
  Benefit: Our high-throughput multiplexing capabilities and non-invasive sample analysis maximize the data yield from a single, small-volume sample, reducing the number of animals needed per study.
• Pain Point: The complexity of analyzing and interpreting multi-omics data.
  Benefit: Our integrated bioinformatics pipelines and expert reporting transform raw data into clear, actionable insights, providing a systems-level understanding of your project.

Distributed under Unsplash License, from Unsplash.

Key Benefits of Our Service

At Creative Biolabs, our commitment is to provide a service that is as advanced as your science. Our NHP Bioanalysis & Biomarker services offer a distinct advantage over conventional methods.

• Rapid Response Speed: With an efficient, streamlined workflow, ensuring your project progresses without unnecessary delays.
• Reliable NHP Resources: Through our established network of accredited suppliers, we ensure a stable and ethical supply of NHPs, mitigating the risk of supply chain disruptions that have plagued the industry.
• Customization: We offer fully customizable panels and assays to meet your unique research needs, ensuring that the data you receive is directly relevant to your specific scientific questions.
• Reporting Depth: Our comprehensive reports go beyond raw numbers, providing expert data interpretation and actionable conclusions that save you time and resources. Published data supports our ability to identify subtle but significant biomarker changes in models of aging and disease.

How Creative Biolabs' Services Can Assist Your Project?

Our service is designed as a clear, step-by-step process that provides transparency and predictable outcomes, ensuring you receive the precise data you need to drive your project forward.

Key Deliverables

• Comprehensive Lab Report: A professionally prepared document detailing the methods, quality control data, and a summary of key findings.
• Raw and Processed Data: All raw data files and a clean, organized spreadsheet of the processed data for your records and internal analysis.
• Graphical Summaries: Annotated charts and figures that visually represent the data and key trends.
• Full Data Annotation: Detailed annotations on all biomarkers, including their known biological functions and relevance to your study.

Capabilities & Partnerships

Service-Specific Data

• Annual Sample Size: Over 50,000 samples analyzed per year.
• Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
• Study Pass Rate: 99%+ success rate in meeting study endpoints.

Our Valued Partners

Frequently Asked Questions

Contact Us

Creative Biolabs provides more than just data; we deliver the insights you need to make critical decisions and accelerate your drug development pipeline. Our NHP Bioanalysis & Biomarker services combine advanced technology, expert analysis, and a commitment to efficiency, allowing you to focus on the science that matters most. To learn more about how our services can support your next project or to discuss your specific research needs, please reach out to our team of specialists.